Webinar Summary
- Learn about translational and predictive animal models of Inflammatory Bowel Disease (IBD), Graft versus Host Disease (GVHD), and pulmonary disease
- Understand the basic components of a successful and comprehensive study design in these therapeutic areas
- Review the typical disease induction approach, disease kinetics, responses to standard of care therapies, and standard endpoints/outcomes that are assessed in these models
- Understand how you can work with BioModels to support your drug development efforts using either established disease models or validating new models and endpoints
Predominantly inflammation driven diseases like acute lung injury, asthma, Crohn's Disease, Ulcerative Colitis and Graft vs Host Disease (GvHD) impact a large and diverse patient population and present a major opportunity for innovation in drug discovery. In this webinar, Drs. Andrew Borkowski and Nicole Smith discuss preclinical models, including models of Inflammatory Bowel Disease (IBD)/colitis, GvHD, and pulmonary disease, focusing on the utility of clinically relevant endpoints that create highly translational models of human disease.
Presenters
Andrew Borkowski
Dr. Borkowski joined Biomodels in 2017 and has diverse interests in the field of immunology and currently works on inflammatory, fibrotic, and pulmonary disease models.
Nicole Smith
Dr. Smith joined Biomodels in 2017 and is interested in model development and diverse pre-clinical indications, currently focusing on IBD, arthritis, and mucositis.
Sponsor
Biomodels, LLC
Content Partners
Scientist.com
Scientist.com is the world’s largest and first platform built for the intricacies of scientific outsourcing.
We help pharmaceutical and biotechnology organizations discover, engage, manage, and scale relationships with the providers that support every stage of the pipeline—from discovery and preclinical research to clinical development, manufacturing, medical affairs, and commercialization. Through a centralized platform, organizations can access a global network of 6,000+ providers, streamline sourcing and procurement workflows, maintain compliance, manage supplier relationships, and leverage data-driven insights to make faster, more informed decisions.
Today, Scientist.com supports more than 130 life science organizations, including 24 of the world's top 30 pharmaceutical companies, helping teams reduce operational complexity, accelerate timelines, and bring innovations to patients faster. Our mission is to make it possible to cure all human disease by 2050.
